Cargando…
Effect of Immune Checkpoint Inhibitors Plus Chemotherapy on Advanced Gastric Cancer Patients with Elevated Serum AFP or Hepatoid Adenocarcinoma
PURPOSE: Alpha-fetoprotein-producing gastric cancer (AFPGC) and hepatoid adenocarcinoma of stomach (HAS) are rare types of gastric cancer, with specific clinical manifestations and poor prognosis. The standardized treatment process of such cancers remains elusive. We aim to investigate the efficacy...
Autores principales: | Li, Wei, Li, Qian, Yu, Yiyi, Wang, Yan, Chen, Erbao, Chen, Lingli, Wang, Zhiming, Cui, Yuehong, Liu, Tianshu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7646478/ https://www.ncbi.nlm.nih.gov/pubmed/33173344 http://dx.doi.org/10.2147/CMAR.S276969 |
Ejemplares similares
-
Genomic profiling and the impact of MUC19 mutation in hepatoid adenocarcinoma of the stomach
por: Zhu, Mengxuan, et al.
Publicado: (2022) -
AFP-producing hepatoid adenocarcinoma of the stomach: a case report
por: Vlachostergios, Panagiotis J, et al.
Publicado: (2009) -
AFP-producing hepatoid adenocarcinoma (HAC) of peritoneum and omentum: a case report and literature review
por: Zou, Man, et al.
Publicado: (2019) -
Genomic Profiles of a Patient of Pulmonary Hepatoid Adenocarcinoma With High AFP Level: A Case Report
por: Li, Jinglin, et al.
Publicado: (2019) -
Hepatoid Adenocarcinoma Of The Lung Metastasizing To The Gingiva
por: Wang, Chunhua, et al.
Publicado: (2019)